 1 Agents affecting nervous system and sensory organs
|
|
 2 Agents affecting individual organs
|
21 Cardiovascular agents
|
211 Cardiotonics
|
212 Antiarrhythmic agents
|
213 Diuretics
|
214 Antihypertensives
|
215 Capillary stabilizers
|
216 Vasoconstrictors
|
217 Vasodilators
|
218 Hyperlipidemia agents
|
 2181 Linoleic acids
|
2182 Lecithins
|
2183 Clofibrates
|
2189 Others
|
D04267 Polyenephosphatidyl choline (JAN)
D03343 Dextran sulfate sodium sulfur 5 (JP18); Dextran sulfate sodium sulfur 18 (JP18)
D00434 Simvastatin (JP18/USP/INN)
D00893 Pravastatin sodium (JP18/USP)
D00892 Fluvastatin sodium (JAN/USP)
D02258 Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP18)
D01915 Rosuvastatin calcium (JP18/USP)
D01862 Pitavastatin calcium (JAN)
D10568 Pitavastatin calcium hydrate (JP18)
D02690 Cholestyramine resin (USP); Colestyramine (JAN/INN)
D00476 Probucol (JP18/USP/INN)
D05255 Omega-3-acid ethyl esters (USP)
D01966 Ezetimibe (JAN/USP/INN)
D09638 Lomitapide mesylate (USAN); Lomitapide mesilate (JAN)
D10557 Evolocumab (USAN/INN); Evolocumab (genetical recombination) (JAN)
D12293 Inclisiran sodium (JAN)
D11753 Evinacumab (USAN/INN); Evinacumab (genetical recombination) (JAN)
D10385 Ezetimibe and atorvastatin
D12438 Pitavastatin calcium and ezetimibe
D01934 Colestilan chloride (USAN); Colestilan (INN); Colestimide (JP18)
D01221 gamma Oryzanol (JAN)
D01291 Nicomol (JP18/INN)
D01892 Icosapent ethyl (USAN); Ethyl icosapentate (JP18)
D04268 Elastase ES
D11520 Ezetimibe and rosuvastatin
|
219 Miscellaneous
|
22 Respiratory organ agents
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
26 Epidermides
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan